These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension and ECG-verified left ventricular hypertrophy in the LIFE-study]. Ibsen H; Pedersen OL; Dahlöf B; Kjeldsen SE; Lindholm LH Ugeskr Laeger; 2003 Jan; 165(5):456-9. PubMed ID: 12599843 [TBL] [Abstract][Full Text] [Related]
26. Left ventricular hypertrophy and hypertension. Katibi IA Niger J Med; 2004; 13(1):8-17. PubMed ID: 15296101 [TBL] [Abstract][Full Text] [Related]
27. [The hypertensive heart: its pathogenesis, diagnosis and treatment]. Rudyk BI; Barna ON Lik Sprava; 1992 May; (5):3-9. PubMed ID: 1441406 [No Abstract] [Full Text] [Related]
29. Keeping tabs on your heart while treating BP. Johns Hopkins Med Lett Health After 50; 2005 May; 17(3):3, 7. PubMed ID: 15841551 [No Abstract] [Full Text] [Related]
30. The year in hypertension. Williams B J Am Coll Cardiol; 2008 May; 51(18):1803-17. PubMed ID: 18452788 [No Abstract] [Full Text] [Related]
31. [Results from the LIFE study: promising effects of new hypertensive agents]. Nilsson P; Kahan T Lakartidningen; 2002 Apr; 99(16):1792-4. PubMed ID: 12043477 [No Abstract] [Full Text] [Related]
33. Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study. Olsen MH; Wachtell K; Beevers G; Dahlöf B; de Simone G; Devereux RB; de Faire U; Fyhrquist F; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Lyle PA; Nieminen MS; Omvik P; Oparil S; Wedel H J Hypertens; 2009 Mar; 27(3):567-74. PubMed ID: 19262226 [TBL] [Abstract][Full Text] [Related]
34. Proteomic analysis of early left ventricular hypertrophy secondary to hypertension: modulation by antihypertensive therapies. Gallego-Delgado J; Lazaro A; Osende JI; Esteban V; Barderas MG; Gomez-Guerrero C; Vega R; Vivanco F; Egido J J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S159-64. PubMed ID: 17130255 [TBL] [Abstract][Full Text] [Related]
35. [Regression of left ventricular hypertrophy in hypertensive heart disease]. Hennersdorf MG; Schannwell CM; Schwartzkopff B; Strauer BE Herz; 2003 Dec; 28(8):764-78. PubMed ID: 14689112 [TBL] [Abstract][Full Text] [Related]
36. Transcriptome of hypertension-induced left ventricular hypertrophy and its regression by antihypertensive therapies. Gallego-Delgado J; Connolly SB; Lázaro A; Sadlier D; Kieran NE; Sugrue DD; Doran P; Brady HR; Osende J; Egido J Hypertens Res; 2009 May; 32(5):347-57. PubMed ID: 19325563 [TBL] [Abstract][Full Text] [Related]
37. Prevalence of paroxysmal atrial fibrillation depending on the regression of left ventricular hypertrophy in arterial hypertension. Hennersdorf MG; Schueller PO; Steiner S; Strauer BE Hypertens Res; 2007 Jun; 30(6):535-40. PubMed ID: 17664857 [TBL] [Abstract][Full Text] [Related]
38. [Arterial hypertension and heart diseases. Diagnostic-therapeutic guidelines. Joint Commission of the National Association of Hospital Cardiologists, the Italian Society of Cardiology and the Italian Society of Arterial Hypertension]. Agabiti-Rosei E; Giovannini E; Mancia G; Novo S; Pede S; Rappelli A; Sau F; Trevi G; Verdecchia P Cardiologia; 1999 Mar; 44(3):299-312. PubMed ID: 10327733 [No Abstract] [Full Text] [Related]
39. Further evidence for low-dose combinations in patients with left ventricular hypertrophy. Dahlöf B J Hum Hypertens; 2005 Jun; 19 Suppl 1():S9-14. PubMed ID: 16075032 [TBL] [Abstract][Full Text] [Related]
40. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study. Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]